The role of MicroRNAs in the management of liver cancer

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 241-251

  Banaudha, Krishna K ^a   Verma, Mukesh ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biogenesis; Biomarkers; Epidemiology; Epigenetics; Hepatitis; Liver cancer; MiRNA; Treatment

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; LUCIFERASE; MICRORNA; TUMOR MARKER;

ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; ENZYME ASSAY; FLUORESCENCE; GENETIC EPIGENESIS; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; METHODOLOGY; PHYSIOLOGY; RISK FACTOR;

DNA POLYMERASE I; ENZYME ASSAYS; EPIGENESIS, GENETIC; FLUORESCENCE; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MICRORNAS; MODELS, BIOLOGICAL; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859958483     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_14     Document Type: Article

References (44)

1. Bala, S., Marcos, M., and Szabo, G. (2009) Emerging role of microRNAs in liver diseases. World J Gastroenterol 15, 5633-5640.
2. Duncavage, E., Goodgame, B., Sezhiyan, A., Govindan, R., and Pfeifer, J. (2010) Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer. J Thorac Oncol 5, 1755-1763.
3. Nana-Sinkam, S. P., Fabbri, M., and Croce, C. M. (2010) MicroRNAs in cancer: Personalizing diagnosis and therapy. Ann N Y Acad Sc 1210, 25-33.
4. Ji, J. and Wang, X. W. (2009) New kids on the block: Diagnostic and prognostic microRNAs in hepatocellular carcinoma. Cancer Biol Ther 8, 1686-1693.
5. Zhang, B., Pan, X., Cobb, G. P., Anderson, and T.A. (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302, 1-12. (Pubitemid 46096921)
6. Neal, C. S., Michael, M. Z., Rawlings, L. H., Van der Hoek, M. B., and Gleadle, J. M. (2010) The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 8, 64-65.
7. Zhang, H., Cai, X., Wang, Y., Tang, H., Tong, D., and Ji, F. (2010) microRNA-143, downregulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24, 1363-1369.
8. Liu, W. H., Yeh, S. H., Lu, C. C., Yu, S. L., Chen, H. Y., Lin, C.Y., Chen, D.S., and Chen, P. J. (2009) MicroRNA-18a prevents estrogen receptor-Alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 136, 683-693.
9. Gramantieri, L., Fornari, F., Callegari, E., Sabbioni, S., Lanza, G., Croce, C. M., Bolondi, L., and Negrini, M. (2008) MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 12, 2189-2204.
10. Su, H., Yang, J. R., Xu, T., Huang, J., Xu, L., Yuan, Y., and Zhuang, S. M. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142.
11. Vinciguerra, M., Sgroi, A., Veyrat-Durebex, C., Rubbia-Brandt, L., Buhler, L. H., and Foti, M. (2009) Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology 49, 1176-1184.
12. Xu, T., Zhu, Y., Wei, Q. K., Yuan, Y., Zhou, F., Ge, Y. Y., Yang, J. R., Su, H., and Zhuang, S. M. (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29, 2126-1131.
13. Houzet, L., Yaung, M. L., de Lame, V., Desai, D., Smith, S. M., and Jeang, K. T. (2008) MicroRNA profile changes in human immunodefi ciency virus type 1 (HIV-1) seropositive individuals. Rerovirology 5, 118-119.
14. Cullen, B. R. (2006) Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 7, 563-567. (Pubitemid 43797336)
15. Berkhout, B. and Jeang, K. T. (2007) RISCy business MicroRNAs, pathogenesis, and viruses. J Biol. Chem. 282, 26641-26645. (Pubitemid 47501890)
16. Padersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisasi, F. V., and David, M. (2008) Control of HCV Replication: When Size Does Not Matter. Hepatology 47, 1092-1094.
17. Padersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisasi, F. V., and David, M. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 18, 910-923.
18. Winter, J. and Diederichs, S. (2011) MicroRNA biogenesis and cancer. Methods Mol Biol 676, 6713-6722.
19. Rossi, J. J. (2009) New hope for a microRNA therapy for liver cancer. Cell 137, 990-992.
20. Banaudha, K., Kaliszewski, M., Korolnek, T., Florea, L., Yeung, M. L., Kuan, K. T., and Kumar, A. (2011a) MicroRNA silencing of tumor suppressor DLC-1 promotes effi cient hepatitis C virus replication in primary human hepatocytes. Hepatology 53 (1) 53-61.
21. Banaudha, K., Orenstein, J. M., Korolnek, T. St Laurent, G. C. 3rd, Wakita, T., and Kumar A. (2010b) Primary hepatocyte culture supports hepatitis C virus replication: A model for infectionassociated hepatocarcinogenesis. Hepatology 51, 1922-1932.
22. Chen, C., Tan, R., Wong, L., Fekete, R., and Halsey, J. (2011) Quantitation of microRNAs by real-Time RT-qPCR. Methods Mol Biol 687, 113-134.
23. Yeung, M. L., Bennasser, Y., Myers, T. G., Jiang, G., Benkirane, M., and Jeang, K. T. (2005) Changes in microRNA expression profi les in HIV-1-Transfected human cells. Retrovirology 28, 2, 81.
24. Xiong, Y., Fang, J. H., Yun, J. P., Yang, J., Zhang, Y., Jia, W. H., and Zhuang, S. M. (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51, 836-845.
25. Fontana, R. J., Dienstag, J. L., Bonkovsky, H. L., Sterling, R. K., Naishadham, D., Goodman, Z. D., Lok, A. S., Wright, E. C., Su, G. L., and HALT-C Trial Group. (2010) Serum fi brosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 59, 1401-1409.
26. Kaibori, M., Ishizaki, M., Matsui, K., and Kwon, A. H. (2010) Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Onco. 102, 462-468.
27. Liu, C., Shen, J., Pan, C., Yang, L., Mou, S., Wang, H., and Liang, Y. (2010) MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma. Am J. Clin. Pathol 134, 235-241.
28. Beppu, T., Sugimoto, K., Shiraki, K., Tameda, M., Kusagawa, S., Nojiri, K., Tanaka, J., Yamamoto, N., Takei, Y., Takaki, H., Uraki, J., Nakatsuka, A., Yamakado, K., and Takeda, K. (2010) Clinical signifi cance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation. J. Mol. Med. 26, 425-433.
29. Suriawinata, A. and Thung, S. N. (2010) Molecular signature of early hepatocellular carcinoma. Oncology 78, 36-39.
30. Deng, L., Adachi, T., Kitayama, K., Bungyoku, Y., Kitazawa, S., Ishido, S., Shoji, I., and Hotta, H. (2008) Hepatitis C virus infection induces apoptosis through a Bax-Triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82, 10375-10385. (Pubitemid 352691171)
31. Varnholt, H., Drebber, U., Schulze, F., Wedemeyer, I., Schirmacher, P., Dienes, H. P., and Odenthal, M. (2008) MicroRNA gene expression profile of hepatitis C virus-Associated hepatocellular carcinoma. Hepatology 47, 1223-1232. (Pubitemid 351547908)
32. Deng, Y., Shipps, G. W. Jr., Wang, T., Popovici-Muller, J., Rosner, K. E., Siddiqui, M. A., Duca, J., Cooper, A. B., and Cable, M. (2009) Discovery of 4H-pyrazolo[1,5-A]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase. Bioorg Med Chem Lett 19, 5363-5367.
33. Deng, Y. B., Nagae, G., Midorikawa, Y., Yagi, K., Tsutsumi, S., Yamamoto, S., Hasegawa, K., Kokudo, N., Aburatani, H., and Kaneda, A. (2010) Identifi cation of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Cancer Sci 101, 1501-1510.
34. Sakamoto, M., Effendi, K., and Masugi, Y. (2010) Molecular diagnosis of multistage hepatocarcinogenesis. Jpn J. Clin. Oncol 40, 891-896.
35. Ji, J., Zhao, L., Budhu, A., Forgues, M., Jia, H. L., Qin, L. X., Ye, Q. H., Yu, J., Shi, X., Tang, Z. Y., and Wang, X. W. (2010) Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol. 52, 690-697.
36. Kumar, A. and Jeang, K. T. (2008) Insights into cellular microRNAs and human immunodefi ciency virus type 1 (HIV-1). J Cell Physiol 216, 327-331. (Pubitemid 351898458)
37. Beaulieu, P. L., Bös, M., Bousquet, Y., Fazal, G., Gauthier, J., Gillard, J., Goulet, S., LaPlante, S., Poupart, M. A., Lefebvre, S., McKercher, G., Pellerin, C., Austel, V., and Kukolj, G. (2004) Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: Discovery and preliminary SAR of benzimidazole derivatives. Bioorg Med Chem Let. 14, 119-124. (Pubitemid 38016210)
38. Gal-Tanamy, M., Zemel, R., Bachmatov, L., Jangra, R. K., Shapira, A., Villanueva, R. A., Yi, M., Lemon, S. M., Benhar, I., and Tur-Kaspa, R. (2010) Inhibition of protease-inhibitorresistant hepatitis C virus replicons and infectious virus by intracellular intrabodies. Antiviral Res 88, 95-106.
39. Stenvang, J., Lindow, M., and Kauppinen, S. (2008) Targeting of microRNAs for therapeutics. Biochem Soc Trans 36, 1197-1200.
40. Priet, S., Zlatev, I., Barvik, I., Geerts, K., Leyssen, P., Neyts, J., Dutartre, H., Canard, B., Vasseur, J. J., Morvan, F., and Alvarez, K. (2010) 3 ¢ -Deoxy phosphoramidate dinucleosides as improved inhibitors of hepatitis C virus subgenomic replicon and NS5B polymerase activity. J Med Chem 53, 6608-6617.
41. Arbuthnot, P. and Thompson, L. J. (2008) Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol 14, 1670-1681. (Pubitemid 351493373)
42. Suzuki, T., Sakurai, F., Nakamura, S., Kouyama, E., Kawabata, K., Kondoh, M., Yagi, K., and Mizuguchi, H. (2008) miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol Ther 16, 1719-1726.
43. Gantier, M. P., Sadler, A. J., and Williams, B. R. (2007) Fine-Tuning of the innate immune response by micrRNAs. Immunol Cell Biol 85, 458-462. (Pubitemid 47367503)
44. Kim, D. H. and Rossi, J. J. (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genes 8, 173-184.